Protein-Based Nanoparticle Vaccines for SARS-CoV-2

Protein-Based Nanoparticle Vaccines for SARS-CoV-2

The pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has upended healthcare systems and economies around the world. Rapid understanding of the structural biology and pathogenesis of SARS-CoV-2 has allowed the development of emergency use or FDA-approved vaccines an...

Full description

Bibliographic Details
Main Authors: Hyo-Dong Sung, Nayeon Kim, Yeram Lee, Eun Jung Lee
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
SARS-CoV-2
protein nanoparticles
vaccines
nanovaccine
nanomedicine
protein-based nanotechnology
Online Access:https://www.mdpi.com/1422-0067/22/24/13445

Similar Items

Similar Items